GlassScriptPhysician profile
Erica Papathomas
NPI 1104850270
$838.56
in general payments reported to CMS, 2019-2025
11 companies · $164 in 2025
The $164 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $113 · 2020: $41.71 · 2022: $347 · 2023: $53.49 · 2024: $119 · 2025: $164.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $337.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $336.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $233.89 | 2022-2025 | |
| Stryker Corporation | $191.66 | 2022-2025 | Asnis, Flexband, 7 X 23mm Citrelock Implant |
| Triad Life Sciences INC. | $109.61 | 2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $95.75 | 2019-2022 | |
| Orthofix Medical, INC. | $71.05 | 2019-2025 | Physio-Stim |
| Osteomed LLC | $40.81 | 2020-2022 | |
| Integra Lifesciences Corporation | $25.28 | 2019 | |
| Acumed LLC | $21.00 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $18.90 | 2023 | Seglentis |
| Sebela Pharmaceuticals INC. | $17.69 | 2022 | |
| Medtronic Vascular, INC. | $12.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erica Papathomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.